{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:30:19Z","timestamp":1776882619434,"version":"3.51.2"},"reference-count":63,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["835210"],"award-info":[{"award-number":["835210"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Science Fund (FWF)","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"Austrian Science Fund (FWF)","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"Austrian Science Fund (FWF)","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"Austrian Science Fund (FWF)","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"Austrian Science Fund (FWF)","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"ERA PerMed (JAKSTAT-TARGET)","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"ERA PerMed (JAKSTAT-TARGET)","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"ERA PerMed (JAKSTAT-TARGET)","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"ERA PerMed (JAKSTAT-TARGET)","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"ERA PerMed (JAKSTAT-TARGET)","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"ERA-NET (ERANET-PLL)","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"ERA-NET (ERANET-PLL)","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"ERA-NET (ERANET-PLL)","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"ERA-NET (ERANET-PLL)","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"ERA-NET (ERANET-PLL)","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"Linde Family Foundation, NIBR, 3DC, and DDCF","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"Linde Family Foundation, NIBR, 3DC, and DDCF","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"Linde Family Foundation, NIBR, 3DC, and DDCF","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"Linde Family Foundation, NIBR, 3DC, and DDCF","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"Linde Family Foundation, NIBR, 3DC, and DDCF","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"National Institute of General Medical Sciences from the National Institutes of Health","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"National Institute of General Medical Sciences from the National Institutes of Health","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"National Institute of General Medical Sciences from the National Institutes of Health","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"National Institute of General Medical Sciences from the National Institutes of Health","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"National Institute of General Medical Sciences from the National Institutes of Health","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"NIH-ORIP HEI","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"NIH-ORIP HEI","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"NIH-ORIP HEI","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"NIH-ORIP HEI","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"NIH-ORIP HEI","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]},{"name":"U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory","award":["835210"],"award-info":[{"award-number":["835210"]}]},{"name":"U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory","award":["SFB-F06109"],"award-info":[{"award-number":["SFB-F06109"]}]},{"name":"U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}]},{"name":"U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}]},{"name":"U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>NK\/T-cell lymphoma (NKTCL) and \u03b3\u03b4 T-cell non-Hodgkin lymphomas (\u03b3\u03b4 T-NHL) are highly aggressive lymphomas that lack rationally designed therapies and rely on repurposed chemotherapeutics from other hematological cancers. Histone deacetylases (HDACs) have been targeted in a range of malignancies, including T-cell lymphomas. This study represents exploratory findings of HDAC6 inhibition in NKTCL and \u03b3\u03b4 T-NHL through a second-generation inhibitor NN-429. With nanomolar in vitro HDAC6 potency and high in vitro and in cellulo selectivity for HDAC6, NN-429 also exhibited long residence time and improved pharmacokinetic properties in contrast to older generation inhibitors. Following unique selective cytotoxicity towards \u03b3\u03b4 T-NHL and NKTCL, NN-429 demonstrated a synergistic relationship with the clinical agent etoposide and potential synergies with doxorubicin, cytarabine, and SNS-032 in these disease models, opening an avenue for combination treatment strategies.<\/jats:p>","DOI":"10.3390\/ph15111321","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:17:48Z","timestamp":1666768668000},"page":"1321","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)\/T-Cell Lymphoma"],"prefix":"10.3390","volume":"15","author":[{"given":"Harsimran Kaur","family":"Garcha","sequence":"first","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"},{"name":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabanita","family":"Nawar","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"},{"name":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3380-7770","authenticated-orcid":false,"given":"Helena","family":"Sorger","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fettah","family":"Erdogan","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"},{"name":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myint Myat Khine","family":"Aung","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abootaleb","family":"Sedighi","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimyupa","family":"Manaswiyoungkul","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"},{"name":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk-Soo","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann","family":"Sch\u00f6nefeldt","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"P\u00f6l\u00f6ske","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirano","family":"Dhe-Paganon","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-7786","authenticated-orcid":false,"given":"Heidi A.","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-8241","authenticated-orcid":false,"given":"Satu M.","family":"Mustjoki","sequence":"additional","affiliation":[{"name":"Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland"},{"name":"Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland"},{"name":"iCAN Digital Precision Cancer Medicine Flagship, 00014 Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Herling","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, 04109 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvin D.","family":"de Araujo","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-9463","authenticated-orcid":false,"given":"Richard","family":"Moriggl","sequence":"additional","affiliation":[{"name":"Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"Gunning","sequence":"additional","affiliation":[{"name":"Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON L5L 1C6, Canada"},{"name":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13045-018-0687-0","article-title":"Treatment of Localized Extranodal NK\/T Cell Lymphoma, Nasal Type: A Systematic Review","volume":"11","author":"Kim","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/annonc\/mdn551","article-title":"Effective Second-Line Chemotherapy for Extranodal NK\/T-Cell Lymphoma Consisting of Etoposide, Ifosfamide, Methotrexate, and Prednisolone","volume":"20","author":"Kim","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International Peripheral T-Cell and Natural killer\/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-Cell Lymphoma: A Review of Clinicopathologic Features, Pathogenesis, and Prognostic Factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-18-0161","article-title":"NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nefeldt, S., Wais, T., Herling, M., Mustjoki, S., Bekiaris, V., Moriggl, R., and Neubauer, H.A. (2021). The Diverse Roles of \u0393\u03b4 T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma. Cancers, 13.","DOI":"10.3390\/cancers13246212"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The Genetic Basis of Hepatosplenic T-Cell Lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2004-01-0002","article-title":"A Systematic Approach to Diagnosis of Mature T-Cell Leukemias Reveals Heterogeneity among WHO Categories","volume":"104","author":"Herling","year":"2004","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic \u0393\u03b4 T-Cell Lymphoma Is a Rare Clinicopathologic Entity with Poor Outcome: Report on a Series of 21 Patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1021\/acs.jmedchem.1c00420","article-title":"Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia","volume":"64","author":"Toutah","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41467-017-02688-6","article-title":"Actionable Perturbations of Damage Responses by TCL1\/ATM and Epigenetic Lesions Form the Basis of T-PLL","volume":"9","author":"Schrader","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"293ra102","DOI":"10.1126\/scitranslmed.aaa5079","article-title":"Epigenetic Therapy Overcomes Treatment Resistance in T Cell Prolymphocytic Leukemia","volume":"7","author":"Hasanali","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"FDD53","DOI":"10.4155\/fdd-2020-0023","article-title":"Recent Advances in Small Molecular Modulators Targeting Histone Deacetylase 6","volume":"2","author":"Xiao","year":"2020","journal-title":"Future Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1242\/jcs.03431","article-title":"HDAC6 Deacetylation of Tubulin Modulates Dynamics of Cellular Adhesions","volume":"120","author":"Tran","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the Crossroads between Cytoskeleton and Cell Signaling by Acetylation and Ubiquitination","volume":"26","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 Is a Microtubule-Associated Deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6-HSP90 Interplay in Malignant Cells","volume":"35","author":"Mahboobi","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-Selective Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6)-Mediated Tubulin Deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00213-020-05525-9","article-title":"HDAC6-Selective Inhibitors Decrease Nerve-Injury and Inflammation-Associated Mechanical Hypersensitivity in Mice","volume":"237","author":"Sakloth","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a Target for Neurodegenerative Diseases: What Makes It Different from the Other HDACs?","volume":"8","author":"Zwick","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_22","first-page":"875824","article-title":"The Role of HDAC6 in Cancer","volume":"2011","author":"Sakamoto","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","article-title":"Class II Histone Deacetylases: From Sequence to Function, Regulation, and Clinical Implication","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1021\/acsomega.1c03628","article-title":"Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications","volume":"6","author":"Citarella","year":"2021","journal-title":"ACS Omega"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2174\/0929867023369402","article-title":"Hydroxamic Acids as Pharmacological Agents","volume":"9","author":"Muri","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/1385272823666190424142821","article-title":"Methods for Hydroxamic Acid Synthesis","volume":"23","author":"Alam","year":"2019","journal-title":"Curr. Org. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/acs.jmedchem.1c01585","article-title":"Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma","volume":"65","author":"Nawar","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.jmedchem.0c01922","article-title":"Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype","volume":"64","author":"Olaoye","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-8891-4_3","article-title":"Quantitative, Real-Time Measurements of Intracellular Target Engagement Using Energy Transfer","volume":"1888","author":"Robers","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/acschembio.5b00143","article-title":"NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions","volume":"10","author":"Machleidt","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc2787","article-title":"Targeting the Cancer Kinome through Polypharmacology","volume":"10","author":"Knight","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial Drug Therapy for Cancer in the Post-Genomic Era","volume":"30","author":"Banerji","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Davies, G., Boeree, M., Hermann, D., and Hoelscher, M. (2019). Accelerating the Transition of New Tuberculosis Drug Combinations from Phase II to Phase III Trials: New Technologies and Innovative Designs. PLoS Med., 16.","DOI":"10.1371\/journal.pmed.1002851"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for Combining Targeted and Conventional Cancer Therapy with Immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ianevski, A., Timonen, S., Kononov, A., Aittokallioid, T., and Giriid, A.K. (2020). SynToxProfiler: An Interactive Analysis of Drug Combination Synergy, Toxicity and Efficacy. PLoS Comput. Biol., 16.","DOI":"10.1371\/journal.pcbi.1007604"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/bioinformatics\/btaa102","article-title":"SynergyFinder: A Web Application for Analyzing Drug Combination Dose-Response Matrix Data","volume":"33","author":"Ianevski","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative Scoring of Differential Drug Sensitivity for Individually Optimized Anticancer Therapies","volume":"4","author":"Yadav","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1021\/jm0703800","article-title":"The First Biologically Active Synthetic Analogues of FK228, the Depsipeptide Histone Deacetylase Inhibitor","volume":"50","author":"Cecil","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","article-title":"Romidepsin: A New Therapy for Cutaneous T-Cell Lymphoma and a Potential Therapy for Solid Tumors","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56747","DOI":"10.18632\/oncotarget.18132","article-title":"Panobinostat, a Histone Deacetylase Inhibitor, Suppresses Leptomeningeal Seeding in a Medulloblastoma Animal Model","volume":"8","author":"Phi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl Sulfoxide to Vorinostat: Development of This Histone Deacetylase Inhibitor as an Anticancer Drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical Toxicities of Histone Deacetylase Inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-21-0238","article-title":"Preclinical Development and First in Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.2018.36.15_suppl.2547","article-title":"A Phase 1b Study of the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Citarinostat (ACY-241) in Combination with Paclitaxel (Pac) in Patients (Pts) with Advanced Solid Tumors (AST)","volume":"36","author":"Gordon","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S1470-2045(16)30375-8","article-title":"Ricolinostat plus Lenalidomide, and Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Multicentre Phase 1b Trial","volume":"17","author":"Yee","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3389\/fonc.2021.696512","article-title":"Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study","volume":"11","author":"Awad","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.18632\/oncotarget.13738","article-title":"Selective HDAC Inhibition by ACY-241 Enhances the Activity of Paclitaxel in Solid Tumor Models","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"North, B.J., Almeciga-Pinto, I., Tamang, D., Yang, M., Jones, S.S., and Quayle, S.N. (2017). Enhancement of Pomalidomide Anti-Tumor Response with ACY-241, a Selective HDAC6 Inhibitor. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173507"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13075-020-02258-0","article-title":"Therapeutic Potential of CKD-506, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Murine Model of Rheumatoid Arthritis","volume":"22","author":"Park","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1111\/bph.15231","article-title":"A Novel Histone Deacetylase 6 Inhibitor Improves Myelination of Schwann Cells in a Model of Charcot\u2013Marie\u2013Tooth Disease Type 1A","volume":"177","author":"Ha","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1107\/S0021889809045701","article-title":"Xia2: An Expert System for Macromolecular Crystallography Data Reduction","volume":"43","author":"Winter","year":"2010","journal-title":"J. Appl. Crystallogr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser Crystallographic Software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1107\/S0907444911047834","article-title":"Use of Knowledge-Based Restraints in Phenix.refine to Improve Macromolecular Refinement at Low Resolution","volume":"68","author":"Headd","year":"2012","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1107\/S0907444913000462","article-title":"Bulk-Solvent and Overall Scaling Revisited: Faster Calculations, Improved Results","volume":"69","author":"Afonine","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1107\/S0021889809023528","article-title":"Automatic Multiple-Zone Rigid-Body Refinement with a Large Convergence Radius","volume":"42","author":"Afonine","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and Development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards Automated Crystallographic Structure Refinement with Phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: All-Atom Structure Validation for Macromolecular Crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpba.2018.08.036","article-title":"A Functional in Vitro Assay for Screening Inhibitors of STAT5B Phosphorylation","volume":"162","author":"Manaswiyoungkul","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"112411","DOI":"10.1016\/j.ejmech.2020.112411","article-title":"PTG-0861: A Novel HDAC6-Selective Inhibitor as a Therapeutic Strategy in Acute Myeloid Leukaemia","volume":"201","author":"Gawel","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.bmcl.2008.04.007","article-title":"Development of a Fluorescence Polarization Based Assay for Histone Deacetylase Ligand Discovery","volume":"18","author":"Mazitschek","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/11\/1321\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:04Z","timestamp":1760144584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/11\/1321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ph15111321"],"URL":"https:\/\/doi.org\/10.3390\/ph15111321","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}